M
Matthew Hickman
Researcher at University of Bristol
Publications - 227
Citations - 7500
Matthew Hickman is an academic researcher from University of Bristol. The author has contributed to research in topics: Population & Poison control. The author has an hindex of 45, co-authored 226 publications receiving 5810 citations. Previous affiliations of Matthew Hickman include National Institute for Health Research & University Hospitals Bristol NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke,Isabelle Andrieux-Meyer,Tanya L. Applegate,Rifat Atun,Jessica R Burry,Hugo Cheinquer,G.M. Dusheiko,Jordan J. Feld,Charles Gore,Max Griswold,Saeed Hamid,Margaret Hellard,Jinlin Hou,J. Howell,Jidong Jia,Natalia Kravchenko,Jeffrey V. Lazarus,Maud Lemoine,Olufunmilayo A. Lesi,Liudmyla Maistat,Brian J. McMahon,Homie Razavi,Teri Roberts,Bryony Simmons,Mark W. Sonderup,C Wendy Spearman,Bridie E Taylor,David L. Thomas,Imam Waked,John W. Ward,Stefan Wiktor,Ayman Abdo,Rakesh Aggarwal,Alessio Aghemo,Bandar Al-Judaibi,Mamun Al Mahtab,Arshad Altaf,Zyaad Ameen,Tarik Asselah,Oidov Baatarkkhuu,Ella Barber,Eleanor Barnes,Pascale Boulet,Louise Burrows,Maia Butsashvili,Erica Chan,Chelsea Chow,Ben Cowie,Chris Cunningham,Alexandre de Araujo,Graciela Diap,G.J. Dore,Joseph Doyle,Manal Elsayed,Emmanuel Fajardo,Edward Gane,Aneley Getahun,David J. Goldberg,Tiffany Got,Matthew Hickman,Andrew F. Hill,Sharon J. Hutchinson,Christopher R. Jones,Saleem Kamili,Amreen Khan,Alice Lee,Tin Yan Lee,Jioiji Malani,Tammy Meyers Morris,Shevanthi Nayagam,Richard Njouom,Ponsiano Ocama,Alisa Pedrana,Rosanna W. Peeling,Amulya Reddy,Jilian A. Sacks,Shiv Kumar Sarin,Yusuke Shimakawa,Marcela Silva,Pavlo Skala,Simon D. Taylor-Robinson,Alexander J. Thompson,Mark Thursz,Alfred Tonganibeia,Jack Wallace,James Ward,Fernando Herz Wolff,Peter Vickerman,Johnny Yau +88 more
TL;DR: Key recommendations include a greater focus on national progress towards elimination with support given, if necessary, through innovative financing measures to ensure elimination programmes are fully funded by 2020.
Journal ArticleDOI
Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts.
Alex S. F. Kwong,Rebecca M. Pearson,Mark Adams,Kate Northstone,Kate Tilling,Daniel J. Smith,Chloe Fawns-Ritchie,Helen Bould,Naomi Warne,Stanley Zammit,David Gunnell,Paul Moran,Nadia Micali,Abraham Reichenberg,Matthew Hickman,Dheeraj Rai,Simon Haworth,Archie Campbell,Drew Altschul,Robin Flaig,Andrew M. McIntosh,Debbie A Lawlor,David J. Porteous,Nicholas J. Timpson +23 more
TL;DR: In both studies, anxiety and depression during the pandemic was greater in younger members, women, those with pre-existing mental/physical health conditions and individuals in socioeconomic adversity, even when controlling for pre-pandemicxiety and depression.
Journal ArticleDOI
Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
Natasha K. Martin,Matthew Hickman,Sharon J. Hutchinson,Sharon J. Hutchinson,David J. Goldberg,Peter Vickerman +5 more
TL;DR: Combining antiviral treatment with OST with HCNSP is critical for achieving substantial reductions in HCV chronic prevalence over 10 years, and empirical studies are required on how best to scale up antiviralreatment and combine treatment with other interventions.
Journal ArticleDOI
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Norah Palmateer,Jo Kimber,Jo Kimber,Matthew Hickman,Sharon J. Hutchinson,Tim Rhodes,David J. Goldberg +6 more
TL;DR: The evidence is weaker than given credit for in the literature and the lack of evidence for effectiveness of NSP vis-à-vis biological outcomes (HCV and HIV incidence/prevalence) reflects the limitations of studies that have been undertaken to investigate these associations.
Journal ArticleDOI
Opioid use disorder.
John Strang,John Strang,Nora D. Volkow,Louisa Degenhardt,Matthew Hickman,Kimberly Johnson,George F. Koob,Brandon D.L. Marshall,Mark W. Tyndall,Sharon L. Walsh +9 more
TL;DR: The risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment, are discussed, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups.